RxDoctor Payments Data

Akhil Patel, MD

Anesthesiology · Washington, DCNPI 1932649860

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Exthera Medical Corporation at 26.7% of the total. Reporting peaked in 2023 at $518 and has fallen 96.9% since, to $16 in 2025.

$675in general payments, 2019–2025

Across 9 payments — averaging $75.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exthera Medical Corporation$180
  • AbbVie$165
  • Amgen$122
  • Hemosonics LLC$101
  • Haemonetics Corporation$65
  • Abiomed$26
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$675100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$675 in reported general payments places this provider in the 85th percentile of 253 anesthesiology providers in District of Columbia.

See all anesthesiology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$72,150
Medicare patients
203
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →